Vacuolar hepatopathy in dogs: 336 Cases (1993-2005)

Journal of the American Veterinary Medical Association

Volumn 229, Issue 2, 2006, Pages 246-252

  Sepesy, Lisa M ^a,b   Center, Sharon A ^a   Randolph, John F ^a   Warner, Karen L ^a   Erb, Hollis N ^a  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; GLUCOCORTICOID; STEROID HORMONE;

ADRENAL DISEASE; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONGENITAL BLOOD VESSEL MALFORMATION; DIABETES MELLITUS; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DOG; DRUG EXPOSURE; GASTROINTESTINAL DISEASE; HEART DISEASE; HEPATOBILIARY DISEASE; HISTOPATHOLOGY; INFECTION; KIDNEY DISEASE; LIVER DISEASE; LIVER TUMOR; NEUROLOGIC DISEASE; NONHUMAN; VACUOLAR HEPATOPATHY;

ALKALINE PHOSPHATASE; ANIMALS; BILIARY TRACT DISEASES; DIAGNOSIS, DIFFERENTIAL; DOG DISEASES; DOGS; FEMALE; GLUCOCORTICOIDS; LIVER; LIVER DISEASES; MALE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

ANIMALIA; CANIS FAMILIARIS;

EID: 33746065677     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.229.2.246     Document Type: Article

References (42)

1. Rogers WA, Ruebner BH. A retrospective study of probable glucocorticoid-induced hepatopathy in dogs. J Am Vet Med Assoc 1977;170:603-606.
2. Badylak SF, Van Vleet JF. Sequential morphologic and clinicopathologic alterations in dogs with experimentally induced glucocorticoid hepatopathy. Am J Vet Res 1981;42:1310-1318.
3. Badylak SE, Van Vleet JF. Tissue gamma glutamyl transpeptidase activity and hepatic ultrastructural alterations in dogs with experimentally induced glucocorticoid hepatopathy. Am J Vet Res 1982;43:649-655.
4. Sanecki RK, Hoffmann WE, Gelberg HB, et al. Subcellular location of corticosteroid-induced alkaline phosphatase in the canine hepatocytes. Vet Pathol 1987;24:296-301.
5. Dillon AR, Spano JS, Powers BD. Prednisolone induced hematologic, biochemical, and histological changes in the dog. J Am Anim Hosp Assoc 1980;16:831-837.
6. Fittschen C, Bellamy EC. Prednisone-induced morphologic and chemical changes in the liver of dogs. Vet Pathol 1984;21:399-406.
7. Rutgers HC, Batt RM, Vaillant C, et al. Subcellular pathologic features of glucocorticoid-induced hepatopathy in dogs. Am J Vet Res 1995;56:898-907.
8. Dillon AR, Sorjonen DC, Powers RD, et al. Effects of dexamethasone and surgical hypotension on hepatic morphologic features and enzymes in dogs. Am J Vet Res 1983;44:1996-1999.
9. Center SA, Warner KL, McCabe J, et al. Evaluation of the influence of S-adenosylmethionine on systemic and hepatic effects of prednisolone in dogs. Am J Vet Res 2005;66:330-341.
10. Center SA. Hepatic lipidosis, glucocorticoid hepatopathy, vacuolar hepatopathy, storage disorders, amyloidosis, and iron toxicity. In: Guilford WG, Center SA, Strombeck DR, et al, eds. Strombeck's small animal gastroenterology. 3rd ed. Philadelphia: WB Saunders Co, 1996;766-801.
11. Solter PF, Hoffmann WE, Chambers MD, et al. Hepatic total 3 alpha-hydroxy bile acids concentration and enzyme activities in prednisone treated dogs. Am J Vet Res 1994;55:1086-1092.
12. Center SA, Slater MR, Manwarren BS, et al. Diagnostic efficacy of serum alkaline phosphatase with gamma-glutamyltransferase in dogs with histologically confirmed hepatobiliary disease: 270 cases (1980-1990). J Am Vet Med Assoc 1992;201:1258-1264.
13. Wellman ML, Hoffmann WE, Dorner JL, et al. Comparison of the steroid-induced, intestinal, and hepatic isoenzymes of alkaline phosphatase in the dog. Am J Vet Res 1982;43:1204-1207.
14. Hadley SP, Hoffmann WE, Kuhlenschmidt MS, et al. Effect of glucocorticoids on alkaline phosphatase, alanine aminotransferase, and gamma-glutamyltransferase in cultured dog hepatocytes. Enzyme 1990;43:89-98.
15. Sanecki RK, Hoffmann WE, Gelberg HB, et al. Subcellular location of corticosteroid-induced alkaline phosphatase in canine hepatocytes. Vet Pathol 1987;24:296-301.
16. Sanecki RK, Hoffmann WE, Dorner JL, et al. Purification and comparison of corticosteroid-induced and intestinal isoenzymes of alkaline phosphatase in dogs. Am J Vet Res 1990;51:1964-1968.
17. Teske E, Rothuizen J, DeBruune JJ, et al. Corticosteroid-induced alkaline phosphatase isoenzyme in the diagnosis of canine hypercorticism. Vet Rec 1989;125:12-14.
18. Jensen AL, Poulsen JSD. Preliminary experience with the diagnostic value of the canine corticosteroid induced alkaline phosphatase isoenzyme in hypercorticism and diabetes mellitus. Zentralbl Veterinarmed [A] 1992;39:342-348.
19. Wilson SM, Feldman EC. Diagnostic value of the steroid-induced isoenzyme of alkaline phosphatase in the dog. J Am Anim Hosp Assoc 1992;28:245-250.
20. Solter PF, Hoffmann WE, Hungerford LL, et al. Assessment of corticosteroid-induced alkaline phosphatase isoenzyme as a screening test for hyperadrenocorticism in dogs. J Am Vet Med Assoc 1993;203:534-538.
21. Geiger TL, Feldman EC, Wallack ST, et al. Lymphoma as a model for chronic illness: effects on adrenocortical function testing. J Vet Intern Med 2003;17:154-157.
22. Wiedemann AL, Charney SC, Barger AM, et al. Assessment of corticosteroid-induced alkaline phosphatase as a prognostic indicatory in canine lymphoma. J Small Anim Pract 2005;46:185-190.
23. Kaplan AJ, Peterson ME, Kemppainen RJ. Effects of disease on the results of diagnostic tests for use in detecting hyperadrenocorticism in dogs. J Am Vet Med Assoc 1995;207:445-451.
24. Chastain CB, Franklin RT, Ganjam VK, et al. Evaluation of the hypothalamic pituitary-adrenal axis in clinically stressed dogs. J Am Anim Hosp Assoc 1986;22:435-442.
25. Center SA, Leveille CA, Baldwin BH, et al. Direct spectrometric determination of serum bile acids in the dog and cat. Am J Vet Res 1984;45:2043-2050.
26. Center SA, ManWarren T, Slater MR, et al. Evaluation of twelve-hour preprandial and two-hour postprandial serum bile acids concentrations for diagnosis of hepatobiliary disease in dogs. J Am Vet Med Assoc 1991;199:217-226.
27. Frank LA, Schmeitzel LP, Oliver JW. Steroidogenic response of adrenal tissues after administration of ACTH to dogs with hypercortisolemia. J Am Vet Med Assoc 2001;218:214-216.
28. Chambon P. The nuclear receptor superfamily: a personal retrospect on the first two decades. Mol Endocrinol 2005;19:1418-1428.
29. Bollen M, Keppens S, Stalmans W. Specific features of glycogen metabolism in the liver. Biochem J 1998;336:19-31.
30. Wiedmeyer CE, Solter PE, Hoffmann WE. Kinetics of mRNA expression of alkaline phosphatase isoenzymes in hepatic tissues from glucocorticoid-treated dogs. Am J Vet Res 2002;63:1089-1095.
31. Prittie JE, Barton LJ, Peterson ME, et al. Pituitary ACTH and adrenocortical secretion in critically ill dogs. J Am Vet Med Assoc 2002;220:615-619.
32. Behrend EN, Kemppainen RJ, Boozer AL, et al. Serum 17-α- hydroxyprogesterone and corticosterone concentrations in dogs with nonadrenal neoplasia and dogs with suspected hyperadrenocorticism. J Am Vet Med Assoc 2005;227:1762-1767.
33. Strombeck DR. Clinicopathologic features of primary and metastatic neoplastic disease of the liver in dogs. J Am Vet Med Assoc 1978;173:267-269.
34. Sterczer A, Meyer HP, Van Sluijs FJ, et al. Fast resolution of hypercortisolism in dogs with portosystemic encephalopathy after surgical shunt closure. Res Vet Sci 1999;66:63-67.
35. Meyer HP, Rothuizen J. Increased free Cortisol in plasma of dogs with portosystemic encephalopathy (PSE). Domest Anim Endocrinol 1994;11:317-322.
36. Roth L. Comparison of liver cytology and biopsy diagnoses in dogs and cats: 56 cases. Vet Clin Pathol 2001;30:35-38.
37. Cole TL, Center SA, Flood SN, et al. Diagnostic comparison of needle and wedge biopsy specimens of the liver in dogs and cats. J Am Vet Med Assoc 2002;220:1483-1490.
38. Wang KY, Panciera DL, Al-Rukibat RK, et al. Accuracy of ultrasound-guided fine-needle aspiration of the liver and cytologic findings in dogs and cats: 97 cases (1990-2000). J Am Vet Med Assoc 2004;224:75-78.
39. Roberts SM, Lavach JD, Macy DW, et al. Effect of ophthalmic prednisolone acetate on the canine adrenal gland and hepatic function. Am J Vet Res 1984;45:1711-1713.
40. Moore GE, Mahaffey EA, Hoenig M. Hematologic and serum biochemical effects of long-term administration of anti-inflammatory doses of prednisone in dogs. Am J Vet Res 1992;53:1033-1037.
41. Glaze MB, Crawford MA, Nachreiner RF, et al. Ophthalmic corticosteroid therapy: systemic effects in the dog. J Am Vet Med Assoc 1988;192:73-75.
42. Meyer DJ, Moriello KA, Feder BM, et al. Effect of otic medications containing glucocorticoids on liver function test results in healthy dogs. J Am Vet Med Assoc 1990;196:743-744.